Skip to content

CONMED CNMD Price / earnings

Price / earnings at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
28×+9.7×
Stryker logo
StrykerSYK
37.7×-12.0×
Boston Scientific logo
Boston ScientificBSX
26.2×-47.5×
Vericel logo
VericelVCEL
76.3×-675×
OSI Systems logo
OSI SystemsOSIS
28.7×+5.7×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
23.2×-1.4×

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.07B-35.6%
Enterprise value$1.89B-24.5%
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Calculated from CONMED’s reported figures.

Based on the most recent quarter.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's price / earnings?
CONMED (CNMD) reported price / earnings of 19.9× in Q1 2026.
How has CONMED's price / earnings changed year-over-year?
CONMED's price / earnings increased by 26.5% year-over-year, from 15.7× to 19.9×.
What is the long-term trend for CONMED's price / earnings?
Over 4 years (2020 to 2025), CONMED's price / earnings has grown at a -47.2% compound annual growth rate (CAGR), from 344.2× to 26.7×.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.